In today’s Health Alert, two popular weight loss drugs went head-to-head in a clinical trial – and one came out on top.

GLP-1 drug Zepbound leads to greater weight and waist loss than Wegovy in 72-week trial, say researchers at European Congress ...

Losing even a moderate amount of weight is associated with reduced progression of diabetes, improved blood pressure and HDL ...

There is no way to target visceral fat specifically, so the best way to reduce it is with overall ... Some people refer to visceral fat as “belly fat.” However, these two kinds of fat are ...